Semaglutide, the active ingredient in Ozempic, has earned widespread attention for its weight loss results. But a growing ...

Differing perspectives among gastric motility experts and regulatory roadblocks impede clinical care, but some companies are ...

It’s frustrating to watch, given my field of study.

Add Yahoo as a preferred source to see more of our stories on Google. If you suffer from a bloated belly, you're not alone. For the past eight years, my clinical practice has seen a steady parade of ...

The FDA declined to approve tradipitant for adults with symptoms of gastroparesis, or delayed gastric emptying, drugmaker Vanda Pharmaceuticals announced on Thursday. Support for the neurokinin-1 ...

The FDA requested additional studies be conducted to provide further evidence of efficacy. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Vanda Pharmaceuticals ...

PITTSBURGH (KDKA) -- Ron Moore didn't know why he was having such incapacitation stomach symptoms. "Like once a week, I was in the emergency room, with vomiting and not being able to keep anything ...

Please provide your email address to receive an email when new articles are posted on . Every August, gastrointestinal care providers and patient advocacy groups celebrate Gastroparesis Awareness ...

Aims: Post-infectious gastroparesis (PIGP) is a subgroup of idiopathic gastroparesis. The aim of this study was to identify post-viral gastroparesis and to characterize clinical and ...

In a Phase 2A Proof-of-Concept trial, the Gastric Emptying Breath Test (GEBT) results demonstrated statistical improvement in gastric emptying in gastroparesis patients receiving 0.5 mg of PCS12852 (6 ...